featured
September 2026
October 2026
November 2026
December 2026
January 2027
February 2027
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The roundtable is made possible by a special educational grant from Pillar Biosciences.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.
Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Illumina.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
September 2026
Medical and surgical gender-affirmation therapies for transgender people have introduced a new spectrum to pathology practices. Sex hormones influence both anatomic and clinical pathology, which can complicate result interpretation for
Medical and surgical gender-affirmation therapies for transgender people have introduced a new spectrum to pathology practices. Sex hormones influence both anatomic and clinical pathology, which can complicate result interpretation for surgical specimens, chemistry, hematology, and microbiology. This activity provides tools to help you successfully serve the transgender population and address the needs of your clinical colleagues in this regard.
This activity was originally presented at CAP23 as part of the activity Anatomic and Clinical Pathology Needs in Transgender Care.
Online course was released on 3/4/2024 and will end on 3/3/2027.
Are your transfusion guidelines up to date? Can you cope with a critical RBC or platelet shortage? This activity succinctly synthesizes current multidisciplinary transfusion practice recommendations for all blood components
Are your transfusion guidelines up to date? Can you cope with a critical RBC or platelet shortage? This activity succinctly synthesizes current multidisciplinary transfusion practice recommendations for all blood components into a logical framework applicable to peer education, blood management programs, and electronic guidance for blood ordering. Included within this activity is a presentation of actual live participants using audience response technology to share benchmarking information on their hospital’s current practices. In addition, you will learn how they can apply up-to-date guidelines to everyday patient problems. Using this foundation, next steps to prepare for and mitigate potential blood shortages are discussed.
This activity was originally presented at CAP23 as part of the activity Can You Bank on Your Blood Supply: Using Blood Wisely and in Shortages.
Online course was released on 3/4/2024 and will end on 3/3/2027.
Direct oral anticoagulants (DOACs), such as apixaban and rivaroxaban, arrived on the market with no need for monitoring. As the use of DOACs expand, it is becoming clearer that their
Direct oral anticoagulants (DOACs), such as apixaban and rivaroxaban, arrived on the market with no need for monitoring. As the use of DOACs expand, it is becoming clearer that their measurement may be necessary in specific situations, and more institutions are integrating either qualitative or quantitative assays. To help you stay abreast of current medical thought, use cases and audience polling examples are included to illustrate and prepare for new testing. Additionally, this activity addresses questions such as: Which type of assay is most appropriate for your institution? How do you validate these assays, many of which are not FDA-cleared? When should they be used? How do you integrate the testing in the ordering menu for clinicians?
This activity was originally presented at CAP23 as part of the activity Optimize or Implement Lab Testing for Xa-Inhibitory Direct Oral Anticoagulant (DOAC) Detection.
October 2026
Wynn Las Vegas, Las Vegas Nevada
Digital pathology is transforming how we diagnose, collaborate, innovate—and ultimately improve patient care. The conversations shaping the future are happening
Digital pathology is transforming how we diagnose, collaborate, innovate—and ultimately improve patient care. The conversations shaping the future are happening at Pathology Visions 2026, October 16–18 in San Diego.
Join the Digital Pathology Association (DPA) for three days of expert education, meaningful collaboration, and the latest advancements in digital pathology and AI. Connect with more than 1,000 pathologists, researchers, laboratory leaders, healthcare professionals, and industry innovators who are driving the next era of precision medicine.
Under this year’s theme, “Connecting Innovation with Purpose,” Pathology Visions 2026 explores the journey of digital pathology from technical innovation to direct patient impact. Sessions will address real-world clinical applications, AI and patient outcomes, emerging technologies and trends, best practices for integrating digital pathology into clinical workflows, and more.
Attendees will have the opportunity to:
Whether you’re looking to gain practical insights, discover emerging technologies, or expand your professional network, #PathVisions26 brings the pathology community together to exchange ideas, spark innovation, forge lasting partnerships, and shape the future of patient care.
Pathology Visions 2026 is an essential event for pathologists, laboratory and healthcare leaders, researchers, and others committed to advancing patient care through the power of digital pathology.
For more information and to register, visit: https://digitalpathologyassociation.org/pathology-visions-conference.
Manchester Grand Hyatt San Diego
Aria Resort & Casino
November 2026
The American Society of Dermatopathology (ASDP) was founded in 1962 to improve the quality of dermatopathology and the treatment
The American Society of Dermatopathology (ASDP) was founded in 1962 to improve the quality of dermatopathology and the treatment of skin diseases. The mission of the ASDP is to improve patient care, support member needs and advance the field of Dermatopathology through education, advocacy and innovation.
The ASDP 63rd Annual Meeting is the premier event designed specifically for dermatopathologists and other physicians with interest in dermatopathology.
The Annual Meeting offers content in:
The Annual Meeting offers an array of educational formats to fit every learner’s needs including lectures on current topics in dermatopathology, pre-meeting online interactive digital microscopy sessions, self-assessment, and poster and oral abstract presentations.
Learn more and register at https://asdp.org/ASDPAnnualMeeting/ASDP-Annual-Meeting/Default.aspx.
Omni Atlanta Hotel at Centennial Park
December 2026
UT MD Anderson's Mitchell Building, Onstead Auditorium
6767 Bertner Ave.
January 2027
Hyatt Regency Phoenix Hotel — Phoenix, Arizona
Join us at the Cleveland Clinic Multispecialty Pathology Symposium Four Seasons Hotel Las Vegas, January 15-17, 2027
Join us at the Cleveland Clinic Multispecialty Pathology Symposium
Four Seasons Hotel Las Vegas, January 15-17, 2027
This pathology symposium will focus on practical discussions of commonly encountered problems in surgical pathology and cytopathology. The goal is to provide useful tips that the speakers utilize in their own practice at the microscope. We aim to address and discuss common problems and avoid an undue focus on esoterica. In this course, renowned subspecialists who are highly sought after for their teaching skills will cover a broad spectrum of cases, including bone and soft tissue pathology, cytology/small biopsies, head and neck pathology, breast pathology, and dermatopathology. Practicing pathologists, fellows, and residents who attend will maintain, develop, and increase their knowledge, competence, and professional performance, with the intent to improve diagnosis and positively impact patient care.
Four Seasons Hotel Las Vegas — Las Vegas, NV
February 2027
The Lodges at Deer Valley — Park City, Utah
The Hythe, A Luxury Resort Vail